Catalyst Wire Dossier Catalyst Wire Dossier

Brenipatide (LY3537031)

LY3537031 · Eli Lilly and Company
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Brenipatide (LY3537031), covering 2026-04-20 to 2026-04-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Brenipatide (LY3537031) in Healthy Participants With Overweight or Obesity [Phase 1]

See pricing